SCHEMBL1677071

SCHEMBL1677071

CC(C)C(C(N)=O)c1ccc(Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 18/20 0.62
ADRB2 P07550 1/20 0.48
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1677068 1.00 FFAR2 (0.62) FFAR2ADRB2MEN1LMNAKMT2A
SCHEMBL1677147 1.00 FFAR2 (0.62) FFAR2ADRB2MEN1LMNAKMT2A
SCHEMBL29639815 0.88 FFAR2 (0.47) FFAR2LMNA
SCHEMBL10614514 0.82 FFAR2 (0.61) FFAR2ADRB2MEN1LMNAKMT2A
SCHEMBL10614521 0.82 FFAR2 (0.61) FFAR2ADRB2MEN1LMNAKMT2A
SCHEMBL1405698 0.82 FFAR2 (0.65) FFAR2MEN1LMNAKMT2A
SCHEMBL1677207 0.82 FFAR2 (0.65) FFAR2MEN1LMNAKMT2A
SCHEMBL1780649 0.82 FFAR2 (0.65) FFAR2MEN1LMNAKMT2A
SCHEMBL3880453 0.82 FFAR2 (0.65) FFAR2MEN1LMNAKMT2A
SCHEMBL68169 0.82 FFAR2 (0.65) FFAR2MEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104404011-A Amidase, coding gene and applications thereof UNIV ZHEJIANG 2015-03-11 CN claimed
US-20090233920-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-09-17 US claimed
EP-1907359-A2 3,5-SUBSTITUTED PIPERIDINE DERIVATIVES EFFECTIVE ON RENIN-RELATED DISORDERS Novartis AG (CH) 2008-04-09 EP claimed
WO-2007006534-A2 PIPERIDINE DERIVATIVES USEFUL IN THE DIAGNOSTIC AND THERAPEUTIC TREATMENT OF DISEASES DEPENDING ON RENIN ACTIVITY NOVARTIS AG (CH) 2007-01-18 WO claimed
EP-0549710-B1 A PROCESS FOR THE PREPARATION OF ENANTIOMERIC 2-ALKANOIC ACIDS DU PONT (US) 1996-02-28 EP claimed
EP-0549710-A1 A PROCESS FOR THE PREPARATION OF ENANTIOMERIC 2-ALKANOIC ACIDS. DU PONT (US) 1993-07-07 EP claimed
EP-0537259-A1 PROCESS FOR PRODUCING ENANTIOMERS OF 2-ARYL-ALKANOIC ACIDS NOVO NORDISK A/S (DK) 1993-04-21 EP claimed
WO-1992005275-A1 A PROCESS FOR THE PREPARATION OF ENANTIOMERIC 2-ALKANOIC ACIDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-04-02 WO claimed
WO-1992001062-A1 PROCESS FOR PRODUCING ENANTIOMERS OF 2-ARYL-ALKANOIC ACIDS NOVO NORDISK A/S (DK) 1992-01-23 WO claimed
JP-5227981-A None JP disclosed
CN-104498466-A Nitrile hydratase and application thereof UNIV ZHEJIANG 2015-04-08 CN disclosed
CN-104450657-A Nitrile hydratase as well as encoding gene and application thereof UNIV ZHEJIANG 2015-03-25 CN disclosed
CN-104404011-A Amidase, coding gene and applications thereof UNIV ZHEJIANG 2015-03-11 CN disclosed
CN-104404011-A Amidase, coding gene and applications thereof UNIV ZHEJIANG 2015-03-11 CN disclosed
US-4254264-A (6-Phenoxy-2-pyridyl) methyl esters of imidates ZOECON CORPORATION (US) 1981-03-03 US disclosed
US-4237158-A FOR PLANT DISEASES; PLANT GROWTH REGULATORS ROHM AND HAAS COMPANY (US) 1980-12-02 US disclosed
US-4220592-A Synthesis of substituted phenylacetic acid SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-09-02 US disclosed
US-4118461-A FUNGICIDES ROHM AND HAAS COMPANY (US) 1978-10-03 US disclosed
US-4115578-A FUNGICIDES ROHM AND HAAS COMPANY (US) 1978-09-19 US disclosed
US-4105762-A Metal salt complexes of 1-substituted aralkyl imidazoles, and methods and compositions for controlling phytopathogenic fungi using them ROHM AND HAAS COMPANY (US) 1978-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233920-A1 ORGANIC COMPOUNDS REN, ACE, AGTR1 FFAR2 3051/4885ADRB2 38/4885MEN1 2386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.